Sarah H. Sutton

873 total citations
42 papers, 658 citations indexed

About

Sarah H. Sutton is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Sarah H. Sutton has authored 42 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 20 papers in Infectious Diseases and 13 papers in Applied Microbiology and Biotechnology. Recurrent topics in Sarah H. Sutton's work include Antibiotic Use and Resistance (13 papers), HIV/AIDS Research and Interventions (8 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Sarah H. Sutton is often cited by papers focused on Antibiotic Use and Resistance (13 papers), HIV/AIDS Research and Interventions (8 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Sarah H. Sutton collaborates with scholars based in United States, Philippines and Saudi Arabia. Sarah H. Sutton's co-authors include Babafemi Taiwo, Evan J. Anderson, Michael Postelnick, Susheel Reddy, Patrick Ryscavage, Teresa Zembower, Marc H. Scheetz, John S. Esterly, Maureen Bolon and Wendy B. Bollag and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Sarah H. Sutton

41 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah H. Sutton United States 14 294 254 84 82 74 42 658
Brian T. Montague United States 16 371 1.3× 339 1.3× 42 0.5× 166 2.0× 72 1.0× 38 786
Uduak Okomo Gambia 17 224 0.8× 201 0.8× 70 0.8× 73 0.9× 229 3.1× 48 814
Kerrie Watson Australia 16 340 1.2× 287 1.1× 65 0.8× 41 0.5× 53 0.7× 23 900
Kelly Echevarria United States 14 337 1.1× 236 0.9× 187 2.2× 68 0.8× 67 0.9× 33 638
Masahiro Ishikane Japan 16 386 1.3× 420 1.7× 216 2.6× 100 1.2× 110 1.5× 120 1.1k
Armel Poda Burkina Faso 13 246 0.8× 187 0.7× 177 2.1× 108 1.3× 44 0.6× 64 583
Guillaume Béraud France 15 213 0.7× 258 1.0× 114 1.4× 59 0.7× 96 1.3× 67 771
Stephen P. Storfer United States 7 635 2.2× 354 1.4× 45 0.5× 44 0.5× 65 0.9× 8 851
Adrie Bekker South Africa 18 382 1.3× 298 1.2× 62 0.7× 35 0.4× 234 3.2× 74 871
Mahesh Swaminathan United States 11 304 1.0× 330 1.3× 62 0.7× 118 1.4× 21 0.3× 30 687

Countries citing papers authored by Sarah H. Sutton

Since Specialization
Citations

This map shows the geographic impact of Sarah H. Sutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah H. Sutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah H. Sutton more than expected).

Fields of papers citing papers by Sarah H. Sutton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah H. Sutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah H. Sutton. The network helps show where Sarah H. Sutton may publish in the future.

Co-authorship network of co-authors of Sarah H. Sutton

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah H. Sutton. A scholar is included among the top collaborators of Sarah H. Sutton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah H. Sutton. Sarah H. Sutton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malczynski, Michael, William J Moore, Andrea Stone, et al.. (2025). Candida auris outbreak in a cardiothoracic transplant intensive care unit: implications for infection prevention practices and keeping pace with an evolving landscape. Infection Control and Hospital Epidemiology. 46(8). 789–796.
2.
Sutton, Sarah H., et al.. (2022). Innate Immune System Activation, Inflammation and Corneal Wound Healing. International Journal of Molecular Sciences. 23(23). 14933–14933. 54 indexed citations
3.
Rhodes, Nathaniel J., Paul R. Yarnold, Anna Pawlowski, et al.. (2022). Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia. Antimicrobial Agents and Chemotherapy. 67(1). e0102322–e0102322. 13 indexed citations
4.
O’Donnell, J. Nicholas, Nathaniel J. Rhodes, Teresa Zembower, et al.. (2021). Impact of early antimicrobial stewardship intervention in patients with positive blood cultures: results from a randomized comparative study. International Journal of Antimicrobial Agents. 59(2). 106490–106490. 3 indexed citations
5.
Miller, Emily S., et al.. (2021). Getting to Zero: A Demonstration Project of Partner HIV Testing in the Prenatal Setting in Chicago, Illinois. AIDS Research and Human Retroviruses. 38(1). 37–44. 2 indexed citations
6.
Roberts, Scott C., et al.. (2020). Cutaneous Manifestations of Campylobacter jejuni Infection. Infectious Diseases in Clinical Practice. 28(2). 61–63. 3 indexed citations
7.
Martin, David W., Amanda K. Gibson, Brian M Hoff, et al.. (2019). Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study. Infection Control and Hospital Epidemiology. 40(3). 269–275. 31 indexed citations
8.
Yee, Lynn M., et al.. (2018). Association between maternal HIV disclosure and risk factors for perinatal transmission. Journal of Perinatology. 38(6). 639–644. 3 indexed citations
9.
McLaughlin, Milena M., et al.. (2017). Use of High-Dose Oral Valacyclovir During an Intravenous Acyclovir Shortage: A Retrospective Analysis of Tolerability and Drug Shortage Management. Infectious Diseases and Therapy. 6(2). 259–264. 14 indexed citations
10.
11.
Krapp, Fiorella, et al.. (2017). Treating complicated carbapenem-resistant enterobacteriaceae infections with ceftazidime/avibactam: a retrospective study with molecular strain characterisation. International Journal of Antimicrobial Agents. 49(6). 770–773. 39 indexed citations
12.
Yee, Lynn M., et al.. (2016). Pill aversion in HIV-infected pregnant women: Theory to practice. Journal of Perinatology. 37(3). 215–219. 4 indexed citations
13.
Kelly, Sean G., et al.. (2016). InappropriateClostridium difficileTesting and Consequent Overtreatment and Inaccurate Publicly Reported Metrics. Infection Control and Hospital Epidemiology. 37(12). 1395–1400. 33 indexed citations
14.
Sutton, Sarah H.. (2014). Infections Associated with Solid Malignancies. Cancer treatment and research. 161. 371–411. 17 indexed citations
15.
Griffith, Matthew, Alan E. Gross, Sarah H. Sutton, et al.. (2012). The Impact of Anti-infective Drug Shortages on Hospitals in the United States: Trends and Causes. Clinical Infectious Diseases. 54(5). 684–691. 50 indexed citations
16.
Sutton, Sarah H., Maureen Bolon, John S. Esterly, et al.. (2012). Prospective Approach to Managing Antimicrobial Drug Shortages. Infection Control and Hospital Epidemiology. 33(7). 745–752. 22 indexed citations
17.
Ryscavage, Patrick, Evan J. Anderson, Sarah H. Sutton, Susheel Reddy, & Babafemi Taiwo. (2011). Clinical Outcomes of Adolescents and Young Adults in Adult HIV Care. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(2). 193–197. 115 indexed citations
18.
McKoy, June M., Charles L. Bennett, Marc H. Scheetz, et al.. (2009). Hepatotoxicity Associated with Long- versus Short-Course HIV-Prophylactic Nevirapine Use. Drug Safety. 32(2). 147–158. 41 indexed citations
19.
Sutton, Sarah H. & John P. Flaherty. (2007). Infections associated with solid tumors. Cancer treatment and research. 96. 105–141. 1 indexed citations
20.
Taiwo, Babafemi, et al.. (2007). Can tumor necrosis factor α blockade predispose to severe babesiosis?. Arthritis Care & Research. 57(1). 179–181. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian T. Montague Breakdown of academic impact, for papers by Uduak Okomo Breakdown of academic impact, for papers by Kerrie Watson Breakdown of academic impact, for papers by Kelly Echevarria Breakdown of academic impact, for papers by Masahiro Ishikane Breakdown of academic impact, for papers by Armel Poda Breakdown of academic impact, for papers by Guillaume Béraud Breakdown of academic impact, for papers by Stephen P. Storfer Breakdown of academic impact, for papers by Adrie Bekker Breakdown of academic impact, for papers by Mahesh Swaminathan
Rankless by CCL
2026